James Hardie Industries plc — FY2024 Form 20-F
Reporting period: Fiscal year ended 31 March 2024, compared principally with FY2023. This is an annual report, not a standalone 2023 fourth-quarter filing; standalone Q4 results are not provided in the supplied text. Financial statements use U.S. GAAP and U.S. dollars unless otherwise indicated.
Business context and financial performance
James Hardie manufactures fiber-cement building products globally and fiber-gypsum and cement-bonded boards in Europe. Its operating segments are North America Fiber Cement, Asia Pacific Fiber Cement and Europe Building Products. North America is the largest segment.
| Metric | FY2024 | FY2023 | Change / context |
|---|---|---|---|
| Net sales | US$3,936.3 million | US$3,777.1 million | Up 4%; pricing and mix gains more than offset a 3% volume decline |
| Gross profit | US$1,588.4 million | US$1,312.0 million | Up about 21%; gross margin approximately 40.4%, versus 34.7% |
| Operating income | US$767.4 million | US$741.4 million | Up 4%; operating margin 19.5%, versus 19.6% |
| Adjusted operating income (EBIT) | US$940.8 million | US$779.8 million | Up 21%; excludes asbestos-related items, AICF expenses and FY2024 project impairment |
| Net income | US$510.2 million | US$512.0 million | Approximately flat |
| Adjusted net income | US$707.5 million | US$605.5 million | Up 17%; non-GAAP measure |
| Diluted EPS | US$1.16 | US$1.15 | Adjusted diluted EPS was US$1.61, versus US$1.36 |
| Net cash from operations | US$914.2 million | US$607.6 million | Up 50% |
| Capital expenditures | US$449.3 million | US$591.3 million | Down from prior-year elevated investment |
| Cash and cash equivalents | US$365.0 million | US$113.0 million | Excludes restricted asbestos cash and investments |
| Gross debt | US$1,129.1 million | US$1,066.1 million | Includes new term-loan borrowings; no RCF borrowings at year-end |
Operating cash flow benefited from net income and non-cash adjustments, plus US$31.1 million of cash generated by working capital; asbestos claims and handling costs paid were US$116.0 million. Financing cash use included US$271.4 million of share repurchases. The company reported US$593.2 million of available revolving-credit capacity. Adjusted ROCE was 55%, versus 48%.
Material changes and segment results
- North America: Sales rose 4% to US$2,891.4 million; volume increased 1% and average price rose 3%. Operating income increased 20% to US$921.1 million and margin rose to 31.9% from 27.5%, aided by lower pulp and freight costs.
- Asia Pacific: Sales rose 4% to US$562.8 million in U.S. dollars; volume fell 4%, while average price increased 8%. Operating income rose 16% to US$166.1 million and margin increased to 29.5% from 26.5%.
- Europe: Sales increased 7% to US$482.1 million in U.S. dollars, while volume fell 13%, primarily due to weaker fiber-gypsum demand. Operating income rose 70% to US$45.0 million and margin increased to 9.3% from 5.8%; price increases and favorable rebate-estimate adjustments helped, while lower volumes raised fixed costs per unit.
- Reported operating income was affected by US$151.7 million of asbestos adjustments, compared with US$37.0 million in FY2023, and a US$20.1 million impairment following cancellation of the Truganina, Australia greenfield project. The higher asbestos charge primarily reflected actuarial estimate changes.
- Interest expense, net, declined to US$15.3 million from US$30.7 million, despite higher gross interest expense, due to higher interest income and capitalized interest. The effective tax rate rose to 32.4% from 29.2%.
Outlook, risks and contingencies
- Management expects FY2025 U.S. residential end markets to decline slightly year over year: expected new-construction growth is projected to be more than offset by weaker repair-and-remodel activity. The addressable markets in Australia and Europe are also expected to contract; the company expects its businesses in both regions to perform above their respective markets.
- FY2025 capital expenditures are estimated at approximately US$500 million to US$550 million. Major projects include Prattville capacity expansions and the Orejo, Spain fiber-gypsum expansion. Management notes projects may face delays, cost overruns or lower-than-expected utilization.
- FY2025 European transfer pricing changes are expected to reduce the Europe segment’s margin by approximately 200 basis points relative to what FY2024 would have shown under the new approach; management says the consolidated effect is nil.
- The asbestos liability was US$989.7 million at 31 March 2024. It is based on an uncertain, undiscounted and uninflated actuarial estimate; actual claims, settlement costs, timing, inflation, insurance recoveries and currency movements could materially change the liability. AICF funding paid in FY2024 was US$91.8 million; approximately A$154 million is anticipated for FY2025.
- Other disclosed exposures include the pending New Zealand Cridge appeal (no reserve recorded; an adverse judgment could be material), an Australian securities class action (no reserve recorded; loss not considered probable and not reasonably estimable), and an Australian Taxation Office transfer-pricing dispute. The ATO estimated additional tax of approximately A$110 million, excluding consequential adjustments, interest and penalties; the company disputes the position and has recorded no reserve.
- Key business risks include housing-market sensitivity, competition and pricing, raw-material and energy costs, foreign exchange, warranty claims, environmental and silica-exposure regulation, cybersecurity, and the long-term asbestos funding obligation. Management said no cybersecurity threat had materially affected, or was reasonably likely to materially affect, the business during FY2024.
- The company cancelled the Truganina greenfield project and recorded the associated impairment. It also repurchased 8.7 million shares for US$271.4 million during FY2024 and announced a further buyback authorization of up to US$250 million through 31 October 2024.
Important facts for investors to verify
- Reconcile reported and adjusted results, particularly the US$151.7 million asbestos adjustment and the definitions and tax treatment of non-GAAP measures.
- Review the latest actuarial assumptions, sensitivity analysis and annual AICF funding requirements; the auditor identified asbestos liability valuation as a critical audit matter.
- Track the ATO dispute and the Cridge appeal, including any change in probability, estimated exposure or recorded reserves.
- Assess FY2025 housing-market trends, segment volumes and margins, and whether expansion projects meet budget, schedule, capacity and utilization expectations.
- Monitor debt maturities, variable-rate exposure, cash generation and buybacks. The filing states the company was compliant with debt covenants and that management expected available cash, operating cash flow and facilities to cover expected needs for the next 12 months.